Results 211 to 220 of about 95,583 (387)

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF guidelines

ESC Heart Failure, EarlyView.
Abstract Aims The guideline‐directed medical therapy (GDMT) sequencing strategy for patients with heart failure (HF) and reduced ejection fraction (HFrEF) underwent a paradigm shift with the 2021 ESC HF guidelines, from stepwise escalation to rapid simultaneous initiation of quadruple therapy.
Kristian Berge, Henrik Schirmer, Tarjei Øvrebotten, Hamza Nahoui, Lars Gullestad, Charlotte Björk Ingul, Torstein Hole, Rune Mo, Kristina Larsby, Tone M. Norekvål, Torbjørn Omland, Stein Ørn, Peder L. Myhre   +12 more
wiley   +1 more source

Interaction Between Na+/Phosphate-Cotransporter and the Adrenoceptors in Myocardial Depression

, 1998
Michael O. Onwochei, Abena O. Ofori, Irene Agodoa   +2 more
openalex   +1 more source

Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Most proteomic analyses in patients with heart failure (HF) focus on the stable ambulatory setting; pathways that drive acute decompensated heart failure (ADHF) are largely uncharacterized. We aimed to examine the associations of cardiometabolic proteins with HF rehospitalization, mortality and diuretic response in patients with ADHF ...
Kenneth T. Hubbell, Veena S. Rao, Rebecca Scherzer, Michael G. Shlipak, Juan B. Ivery‐Miranda, Nisha Bansal, Zachary L. Cox, Jeffrey M. Testani, Michelle M. Estrella   +8 more
wiley   +1 more source

Single-Molecule AFM Studies of Substrate Transport by Using the Sodium-Glucose Cotransporter SGLT1 [PDF]

, 2008
Gruber, H., Hinterdorfer, P., Kinne, R., Puntheeranurak, T.   +3 more
core   +2 more sources

Regulation by Glucocorticoids of Expression and Activity of rBSC1, the Na+-K+(NH4+)-2Cl−Cotransporter of Medullary Thick Ascending Limb [PDF]

, 2000
Amel Attmane-Elakeb, Valérie Sibella, Catherine Vernimmen, Xavier Belenfant, Steven Hébert, Maurice Bichara   +5 more
openalex   +1 more source

Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review

ESC Heart Failure, EarlyView.
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs, Eri Toda Kato, Janani Rangaswami   +2 more
wiley   +1 more source

Reply: Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Adv
Jaiswal V, Hanif M, Mashkoor Y, Prasad T, Fonarow GC.   +4 more
europepmc   +1 more source

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

Circulation, 2014
D. Cherney, B. Perkins, Nima Soleymanlou, M. Maione, V. Lai, Alana Lee, N. Fagan, H. Woerle, O. Johansen, U. Broedl, M. von Eynatten   +10 more
semanticscholar   +1 more source

Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan, Maria Puschita, Diana Lungeanu, Adina Pop‐Moldovan, Luminita Pilat, Dan Darabantiu, Radu Jipa, Radu Ioan Lala   +7 more
wiley   +1 more source

Cyclic Nucleotide Regulation of Na+/Glucose Cotransporter (SGLT1) mRNA Stability [PDF]

, 2000
Jeong Yong Lee, Paul T. Loflin, Constance J. Clancey, Peng Hua, Julia E. Lever   +4 more
openalex   +1 more source